Vikramaditya Yadav
Vikramaditya G. Yadav received his doctorate from the Massachusetts Institute of Technology (MIT) and then went on to conduct post-doctoral research at Harvard University. He joined the faculty at The University of British Columbia (UBC) in the summer of 2014.
His research group utilizes metabolic and enzyme engineering to investigate and customize novel biosynthetic enzymes that can convert biomass-derived feedstocks into better fuels, pharmaceuticals and value-added chemicals. Notably, his group is pioneering the development of ‘biosynthonics’ – a novel paradigm for discovering and synthesizing potent bioactive molecules. They also extend these principles to the design and development of unique bioremediation strategies to rehabilitate the water quality in and around industrial zones. In addition to green engineering, his research group also pursues medical biotechnology research, and their work in this domain primarily focuses on pharmaceutical nanotechnology, drug delivery and tissue engineering. His group also works extensively on development of synthetic biology solutions for limiting the transmission of malaria.
Dr. Yadav has forged strong academic and industrial collaborations, and he is currently working with two biotechnology companies in Vancouver to commercialize his research. He is also a strong advocate of philanthropic science and was awarded the prestigious MIT Legatum Fellowship for his efforts to commercialise a drug manufacturing scheme in the developing world. He is also the Vice-Chair of the Biotechnology Division of the Chemical Institute of Canada.
